Compounds > allicin
Page last updated: 2024-08-24

allicin and captopril

allicin has been researched along with captopril in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mirelman, D; Miron, T; Peleg, E; Rabinkov, A; Rosenthal, T; Wilchek, M1
Mirelman, D; Miron, T; Oron-Herman, M; Rabinkov, A; Rosenthal, T; Sela, BA; Wilchek, M1
Ernsberger, P; Johnson, JL; Koletsky, RJ; Mirelman, D; Rosenthal, T1
Mirelman, D; Rabinkov, A; Rosenthal, T; Younis, F1

Other Studies

4 other study(ies) available for allicin and captopril

ArticleYear
Allylmercaptocaptopril: a new antihypertensive drug.
    American journal of hypertension, 2004, Volume: 17, Issue:1

    Topics: Animals; Antihypertensive Agents; Blood Pressure; Captopril; Disease Models, Animal; Disulfides; Fructose; Hypertension; Hypolipidemic Agents; Insulin; Rats; Rats, Sprague-Dawley; Sulfinic Acids; Triglycerides

2004
The effects of S-allylmercaptocaptopril, the synthetic product of allicin and captopril, on cardiovascular risk factors associated with the metabolic syndrome.
    Atherosclerosis, 2005, Volume: 183, Issue:2

    Topics: Animals; Antihypertensive Agents; Blood Pressure; Captopril; Cyclopropanes; Disease Models, Animal; Disulfides; Homocysteine; Hypertension; Hypoglycemic Agents; Insulin; Male; Metabolic Syndrome; Rats; Rats, Sprague-Dawley; Risk Factors; Sulfinic Acids; Treatment Outcome; Triglycerides

2005
Therapeutic actions of allylmercaptocaptopril and captopril in a rat model of metabolic syndrome.
    American journal of hypertension, 2007, Volume: 20, Issue:8

    Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Captopril; Disease Models, Animal; Disulfides; Dose-Response Relationship, Drug; Drug Combinations; Female; Hypoglycemic Agents; Insulin; Male; Metabolic Syndrome; Rats; Rats, Inbred SHR; Sulfinic Acids; Treatment Outcome

2007
S-allyl-mercapto-captopril: a novel compound in the treatment of Cohen-Rosenthal diabetic hypertensive rats.
    Journal of clinical hypertension (Greenwich, Conn.), 2010, Volume: 12, Issue:6

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Cysteine; Diabetes Mellitus, Type 2; Diastole; Disulfides; Hypertension; Hypoglycemic Agents; Male; Rats; Rats, Inbred SHR; Sulfinic Acids; Systole

2010